当前位置: 首页 >> 检索结果
342. Identifying patients at high risk of decompensated liver disease through unscheduled care attendance data: a retrospective cohort study.
作者: R Swann.;J Lewsey.;D Jamieson.;S Padmanabhan.;J P Pell.;D Mackay.;R Dundas.;J M Friday.;T Q B Tran.;D Brown.;F K Ho.;C Hastie.;M Fleming.;C Geue.;A Stevenson.;C du Toit.;A Fraser.;E H Forrest.
来源: BMC Gastroenterol. 2026年26卷1期126页
Liver cirrhosis is one of the leading causes of mortality and morbidity in those of working age. Mortality from liver disease in the UK has continued to rise over the past decade. A significant proportion of patients presenting with decompensated liver disease have no prior diagnosis of liver disease despite multiple acute healthcare interactions providing opportunities for detection. We aimed to characterise patients presenting to unscheduled care with no known liver disease who subsequently had a liver related admission (DLD), and determine if a simple predictive score could identify those at high risk.
343. mNGS improves the efficiency of infection diagnosis and treatment in acute-on-chronic liver failure.
作者: Yushan Liu.;Qiao Zhang.;Juan Li.;Xiaonan Wu.;Qijuan Zang.;Qiannan Wang.;Pan Huang.;Yamin Wang.;Shuting Zhang.;Siyi Liu.;Chengbin Zhu.;Yingren Zhao.;Taotao Yan.;Yingli He.
来源: BMC Gastroenterol. 2026年26卷1期129页
The early diagnosis of infections in acute-on-chronic liver failure (ACLF) is still difficult. mNGS(metagenomic next-generation sequencing) is a no-bias, sensitive pathogen diagnosis method, and further research on mNGS in ACLF is needed.
344. Interpretable model for early prediction of 28-day mortality in patients with cirrhosis and sepsis: a multi-cohort ICU study.
Cirrhosis complicated by sepsis is a common reason for intensive care unit (ICU) admission and is associated with a markedly increased risk of short-term mortality. However, early assessment of 28-day mortality risk at ICU admission remains uncertain in this population. Existing scoring systems often rely on subjective assessments or clinical variables that may not be readily available at the time of admission, highlighting the need for a simple and objective model based on routinely obtainable data for early risk stratification.
345. Conceptual and operational consistency in defining intestinal failure across randomized controlled trials: a systematic review and meta-research analysis.
作者: Kevin Fernando Montoya-Quintero.;Sandra Valencia.;María Cristina Florián Pérez.;Fabriccio J Visconti-Lopez.;Yadira Marín-Hamburguer.;Ivan David Lozada-Martinez.
来源: BMC Gastroenterol. 2026年26卷1期128页
Intestinal failure (IF) is a rare but serious condition associated with high morbidity, mortality, and healthcare resource use. Although consensus-based definitions for IF exist, their adoption in randomized controlled trials (RCTs) remains uncertain. This variability compromises the comparability of evidence and hinders the development of robust clinical guidelines. The aim of this study was to examine the conceptual and operational consistency of IF definitions in RCTs, assess methodological and reporting quality, and explore implications for research synthesis and clinical decision-making.
346. Inflammatory indices as independent predictors of in-hospital mortality in acute upper gastrointestinal bleeding.
作者: Mustafa Oguz Cumaoglu.;Abdussamed Vural.;Mustafa Alpaslan.;Turgut Dolanbay.;Abdul Ridvan Kulu.;Ercan Sezgin.;Seyyid Rasim Yanmaz.
来源: BMC Gastroenterol. 2026年26卷1期127页
Acute upper gastrointestinal bleeding (UGIB) remains a high-risk emergency with non-negligible in-hospital mortality. Inflammatory indices derived from routine admission tests may provide additional bedside information reflecting inflammatory burden and physiologic reserve, but their prognostic value in UGIB is not well defined.
347. Soil properties and spatial distribution of chronic gastritis in Yanshan County, China: a spatial epidemiological study.
Chronic gastritis is a common gastrointestinal disorder and a potential precursor to gastric cancer. Although environmental factors have been associated with its occurrence, the combined relationships of soil characteristics and demographic variables with its spatial distribution remain unclear. This study aims to quantify associations between soil properties and the spatial distribution of chronic gastritis after accounting for population structure and spatial dependence.
349. Progression of Pancreatic Morphologic Changes and Endocrine Dysfunction After Acute Pancreatitis: Preliminary Results of the Longitudinal Goulash-Plus Cohort Study.
作者: Alexandra Mikó.;Nelli Farkas.;Áron Vincze.;Ferenc Izbéki.;Andrea Szentesi.;Péter Hegyi.; .
来源: Gastroenterology. 2026年170卷3期631-634页 350. Characteristics of Colonoscopy- and Fecal Immunochemical Test-Based Screen-Detected Premalignant Neoplastic Lesions: Results From the COLONPREV Study.
作者: Antoni Castells.;Enrique Quintero.;Maria Pellisé.;Eladio Frías-Arrocha.;Cristina Hernández.;Miquel Serra-Burriel.; .
来源: Gastroenterology. 2026年170卷3期627-630页 352. Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial.
作者: Grishma Hirode.;Hooman F Zangneh.;Orlando Cerocchi.;Korosh Khalili.;Lima A El-Karim.;Christopher Kandel.;Mara Vecchio.;Jeffrey Winick.;Yasuhiro Mori.;Hiroyuki Yamada.;Harry L A Janssen.;Bettina E Hansen.;Morris Sherman.;Jordan J Feld.
来源: Gastroenterology. 2026年170卷3期595-605页
Hepatocellular carcinoma (HCC) surveillance is key to early diagnosis and timely curative treatment. Current strategies are suboptimal with many patients presenting with advanced HCC. This randomized controlled trial compared the combined use of serum biomarker (BM) measurements and abdominal ultrasound (US) with US alone for the diagnosis of early-stage HCC.
353. Metabolic liver disease research in the Arab world: a bibliometric analysis of trends, collaborations, and disparities (2006-2024).
作者: Mortada H El-Shabrawi.;Maito Suoh.;Shadan Almuhaidib.;Saleh A Alqahtani.;Sameer Al Awadhi.;Said A Al-Busafi.;Maheeba Abdulla.;Yasser Fouad.;Maisam Akroush.;Mohamed Tahiri.;Munira Y Altarrah.;Mohammed Eslam.
来源: Minerva Gastroenterol (Torino). 2026年72卷1期37-50页
Non-alcoholic fatty liver disease (NAFLD), which has recently been renamed metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common chronic liver disease globally, including in the Arab world. This study investigates the research output and impact of NAFLD/MAFLD/MASLD in Arab countries until 2024.
354. Assessment of the impact of furosemide use on outcomes in patients with intra-abdominal hypertension: a retrospective cohort study from the MIMIC-IV database.
作者: Jing Wang.;Xiaojie Zhang.;Ziyue Wang.;Zixuan Wang.;Ye Yin.;Jiaqi Li.;Yu Wei.;Qingling Feng.;Xin Hang.;Yurong Wang.;Fei Wu.;Le Xia.;Min Zhu.;Yan Xiao.;Xiaohong Liu.;Jinqiang Zhuang.
来源: BMC Gastroenterol. 2026年26卷1期121页
This study aims to explore the effect of furosemide on the prognosis of patients with intra-abdominal hypertension (IAH).
355. Tumor growth rate for prognostic stratification and treatment optimization in unresectable hepatocellular carcinoma treated with TACE combined with systemic therapy.
作者: Guobin Chen.;Meixia Wang.;Xing Huang.;Zhenzhen Zhang.;Yanfang Wu.;Xiaochun Chen.;Xinkun Guo.;Susu Zheng.;Tanghui Zheng.;Hong Chen.;Jingfang Wu.;Boheng Zhang.
来源: BMC Gastroenterol. 2026年26卷1期119页
Tumor growth rate (TGR) is a dynamic biomarker for evaluating therapeutic response and prognosis in unresectable hepatocellular carcinoma (uHCC) with triple therapy, yet its clinical utility and role in guiding treatment optimization require further validation.
356. Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes.
作者: Camille Danne.;Rodrigo de Oliveira Formiga.;Laura Creusot.;Florian Marquet.;Delphine Sedda.;Laura Hua.;Pauline Ruffié.;Hang-Phuong Pham.;Loic Brot.;Iria Alonso Salgueiro.;Marie-Laure Michel.;Philippe Langella.;Jérémie H Lefevre.;Harry Sokol.;Nathalie Rolhion.
来源: Gastroenterology. 2026年170卷4期704-720页
Faecalibacterium prausnitzii, a highly abundant gut bacterium, has been linked to overall health, and is decreased in several pathologic conditions, such as inflammatory bowel disease (IBD). F prausnitzii has shown anti-inflammatory properties in human and mouse models, notably through the induction of interleukin 10 (IL10) signaling. Here, we investigated which cell types from human blood and intestinal tissue are responsible for producing IL10 induced by F prausnitzii and provide the first mechanistic insights.
357. ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer.
作者: Zhilong Ma.;Mingwei Dong.;Haoqi Pan.;Junyi Xu.;Tingyi Luo.;Wangcheng Xie.;Mingming Xiao.;Xin Wen.;Jie Hua.;Daohai Qian.;Qingcai Meng.;Yufeng Wang.;Di Wu.;Xiaobing Zhang.;Tingsong Yang.;Zhenshun Song.;Wei Wang.;Jin Xu.;Xianjun Yu.;Si Shi.
来源: Gastroenterology. 2026年170卷4期735-752页
Patients with chronic pancreatitis (CP) have a higher risk of developing pancreatic ductal adenocarcinoma (PDAC). Although pancreatitis has been found to promote PDAC initiation and progression, its role in PDAC tumorigenesis remains poorly understood.
358. Association Between Serrated Polyps on Index Examination and Advanced Findings Detected on the Second Surveillance Colonoscopy: Data From the New Hampshire Colonoscopy Registry.
作者: Obaida Dairi.;Joseph C Anderson.;Christopher I Amos.;William Hisey.;Todd A Mackenzie.;Lynn F Butterly.; .
来源: Gastroenterology. 2026年 360. Intestinal transcriptomic analysis and prediction of biomarkers associated with mucosal healing following vedolizumab treatment in ulcerative colitis using machine learning.
作者: Katsuyoshi Ando.;Shin Kashima.;Aki Sakatani.;Hiroaki Konishi.;Atsuo Maemoto.;Takahiro Ito.;Masaki Taruishi.;Kaori Ishiguro.;Mikihiro Fujiya.
来源: BMC Gastroenterol. 2026年26卷1期117页
There is an increasing need for predictors of clinical outcomes in patients with ulcerative colitis (UC). In this exploratory analysis, we aimed to analyze the gene expression profile of intestinal tissues according to treatment outcome in patients with UC treated with vedolizumab and to develop a treatment outcome prediction model.
|